# Semnur Pharmaceuticals, Inc.: Form 8-K, filed Jul 17, 2024

- Company: [Semnur Pharmaceuticals, Inc.](/companies/smnr.md) (CIK 1913577)
- Form: 8-K
- Filed: 2024-07-17
- Accepted by EDGAR: Jul 17, 2024, 14:45 ET
- Period: 2024-07-15
- Accession: 0001213900-24-062099
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1913577/000121390024062099/ea0209521-8k_denali.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1913577/000121390024062099/

## Items reported

- Item 4.01: Change of auditor
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1913577/000121390024062099/ea0209521-8k_denali.htm

Filed Jul 17, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-062099. Last ingested by Listed: Nov 4, 2026, 17:17 ET. No prices; not investment advice.